5 ChatGPT Penny Stock Picks Right Now

3. Ocugen, Inc. (NASDAQ:OCGN)

Number of Hedge Fund Investors: 6

Ocugen, Inc. (NASDAQ:OCGN) makes gene and cell therapies for different diseases. The stock has gained about 140% so far this year. Earlier this month, the FDA cleared Ocugen, Inc.’s (NASDAQ:OCGN) investigational new drug amendment to begin a late-stage clinical trial of its gene therapy product candidate.

A total of six hedge funds tracked by Insider Monkey reported owning stakes in Ocugen, Inc. (NASDAQ:OCGN) as of the end of the fourth quarter of 2023.